NCT00481962已完成不适用
Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 180 人开始时间: 2006年2月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
The main goals of the study are: Assessment of Tygacil's cost-effectiveness; Process cost analysis from a hospital perspective (including length of stay, treatment costs, side effect management costs, costs of monitoring, costs of diagnostic procedures, cost of care (TISS 10 score etc.); Efficacy of Tygacil under usual care conditions (cure rate).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of secondary peritonitis
- •Treatment in an ICU
- •Patient age >18 years
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Cost Effectiveness Analysis of Cholecystectomy, Projected Long Term Outcomes and Complications EvaluationCholelithiasisNCT01117415University Hospitals Cleveland Medical Center37
Unknown
不适用
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerNCT00173524National Taiwan University Hospital200
招募中
不适用
Clinical Trial to Estimate the Efficacy of the Trapezium-Metacarpal (TMC) Prosthesis Compared to Suspensionplasty.First CarpoMetacarpal OsteoartrithisBasal Thumb OsteoartrithisNCT04562753Fundació d'investigació Sanitària de les Illes Balears106
已完成
1 期
Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.Broca's AphasiaStrokeNCT00170703Northstar Neuroscience8
已完成
不适用
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable TherapyDiabetes Mellitus Type 2NCT02843399AstraZeneca15,498